{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:06:56Z","timestamp":1761653216258,"version":"build-2065373602"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>Glanzmann thrombasthenia (GT) is a rare autosomal recessive platelet disorder characterized by abnormalities in platelet aggregation, resulting from quantitative or qualitative defects in integrins \u03b1IIb and \u03b23. Currently, allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only potentially curative therapeutic approach for severe GT. In this report, we present 2 children with GT that underwent successful allo-HSCT, along with 2008 to 2022 data from the Center for International Blood and Marrow Transplant Research and a summary of the existing literature providing further evidence that allo-HSCT can be a curative approach that prevents severe and life-threatening bleeding in GT. Our cases empathize the importance of monitoring flow cytometric platelet integrin \u03b1IIb (GPIIb) and \u03b23 (GPIIIa) detection in identifying potential late graft rejection, which is a more direct assessment of platelet populations, particularly in the case of pretransplant presence of platelet antiglycoprotein GPIIb\/IIIa complex antibodies.<\/jats:p>","DOI":"10.1097\/mph.0000000000003121","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T13:02:49Z","timestamp":1757509369000},"page":"429-435","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Mixed Chimerism and Clinical Outcome of Hematopoietic Stem Cell Transplantation in Glanzmann Thrombasthenia: Experience on 2 Siblings and Literature Review"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2860-487X","authenticated-orcid":false,"given":"Eman T.","family":"Al-Antary","sequence":"first","affiliation":[{"name":"Children\u2019s Hospital of Michigan, Division of Hematology\/Oncology"},{"name":"Children\u2019s Hospital of Michigan, Division of Hematology\/Oncology, Pediatric Blood and Marrow Transplantation Program, Barbara Ann Karmanos Cancer Center"},{"name":"Department of Pediatrics, Central Michigan University College of Medicine, Mt Clemens, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7656-0694","authenticated-orcid":false,"given":"Meera","family":"Chitlur","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Michigan, Division of Hematology\/Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8366-9487","authenticated-orcid":false,"given":"Manisha","family":"Gadgeel","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Michigan, Division of Hematology\/Oncology, Flow Cytometry Laboratory, Detroit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00fcreyya","family":"Sava\u015fan","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Michigan, Division of Hematology\/Oncology"},{"name":"Children\u2019s Hospital of Michigan, Division of Hematology\/Oncology, Pediatric Blood and Marrow Transplantation Program, Barbara Ann Karmanos Cancer Center"},{"name":"Department of Pediatrics, Central Michigan University College of Medicine, Mt Clemens, MI"},{"name":"Children\u2019s Hospital of Michigan, Division of Hematology\/Oncology, Flow Cytometry Laboratory, Detroit"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"R1-20251028","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3324\/haematol.2018.214239","article-title":"Glanzmann thrombasthenia: genetic basis and clinical correlates","volume":"105","author":"Botero","year":"2020","journal-title":"Haematologica"},{"key":"R2-20251028","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/09537104.2017.1371291","article-title":"ITGA2B and ITGB3 gene mutations associated with Glanzmann thrombasthenia","volume":"29","author":"Nurden","year":"2018","journal-title":"Platelets"},{"key":"R3-20251028","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V75.7.1383.1383","article-title":"Glanzmann\u2019s thrombasthenia: the spectrum of clinical disease","volume":"75","author":"George","year":"1990","journal-title":"Blood"},{"key":"R4-20251028","doi-asserted-by":"crossref","first-page":"776927","DOI":"10.3389\/fped.2021.776927","article-title":"Excellent outcome following sibling peripheral blood hematopoietic stem cell transplantation for Glanzmann thrombasthenia: a case report","volume":"9","author":"Li","year":"2021","journal-title":"Front Pediatr"},{"key":"R5-20251028","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/MPH.0b013e31819b7228","article-title":"Sustained engraftment and resolution of bleeding phenotype after unrelated cord blood hematopoietic stem cell transplantation for severe Glanzmann thrombasthenia","volume":"31","author":"Miller","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"R6-20251028","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1365-2141.2002.03936.x","article-title":"Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann\u2019s thrombasthenia and anti-glycoprotein IIb-IIIa antibodies","volume":"119","author":"Martin","year":"2002","journal-title":"Br J Haematol"},{"key":"R7-20251028","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2141.1985.tb07358.x","article-title":"Complete correction of Glanzmann\u2019s thrombasthenia by allogeneic bone-marrow transplantation","volume":"59","author":"Bellucci","year":"1985","journal-title":"Br J Haematol"},{"key":"R8-20251028","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.bbmt.2020.03.018","article-title":"HLA-haploidentical hematopoietic cell transplantation for treatment of nonmalignant diseases using nonmyeloablative conditioning and post-transplant cyclophosphamide","volume":"26","author":"Mallhi","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"R9-20251028","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/pbc.20365","article-title":"Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia","volume":"45","author":"Flood","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R10-20251028","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1111\/j.1399-3046.2009.01251.x","article-title":"Successful unrelated donor cord blood transplantation for Glanzmann\u2019s thrombasthenia","volume":"15","author":"Kitko","year":"2011","journal-title":"Pediatr Transplant"},{"key":"R11-20251028","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/pbc.21888","article-title":"Allogeneic stem cell transplantation for Glanzmann thrombasthenia","volume":"52","author":"Ishaqi","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R12-20251028","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3109\/09537104.2014.987225","article-title":"Use of allogeneic stem cell transplantation for moderate-severe Glanzmann thrombasthenia","volume":"26","author":"Walz","year":"2015","journal-title":"Platelets"},{"key":"R13-20251028","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2141.2007.06890.x","article-title":"Stem cell transplantation for children with Glanzmann thrombasthenia","volume":"140","author":"Connor","year":"2008","journal-title":"Br J Haematol"},{"key":"R14-20251028","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1097\/MPH.0000000000001646","article-title":"Successful use of hematopoietic stem cell transplantation for 2 pediatric cases of Glanzmann thrombasthenia and review of the literature","volume":"42","author":"Friend","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"R15-20251028","first-page":"688","article-title":"Stem cell transplant in severe Glanzmann thrombasthenia in an adult patient","volume":"14","author":"Ramzi","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"R16-20251028","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-0031-1273726","article-title":"Allogeneic hematopoietic stem cell transplantation in Glanzmann thrombasthenia complicated by platelet alloimmunization","volume":"223","author":"Wiegering","year":"2011","journal-title":"Klin Padiatr"},{"key":"R17-20251028","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.bmt.1702139","article-title":"Bone marrow transplantation in severe Glanzmann\u2019s thrombasthenia with antiplatelet alloimmunization","volume":"25","author":"Bellucci","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R18-20251028","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2141.1997.3533167.x","article-title":"Sibling allogeneic bone marrow transplantation in a patient with type I Glanzmann\u2019s thrombasthenia","volume":"99","author":"McColl","year":"1997","journal-title":"Br J Haematol"},{"key":"R19-20251028","first-page":"147","article-title":"Bone marrow transplantation for Glanzmann\u2019s thrombasthenia","volume":"14","author":"Johnson","year":"1994","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 2","key":"R20-20251028","doi-asserted-by":"crossref","first-page":"34","DOI":"10.7861\/clinmedicine.19-2-s34","article-title":"Haemopoietic stem cell transplantation is a curative treatment option with minimal transplant-related complications for patients with severe Glanzmann\u2019s thrombasthenia","volume":"19","author":"Crone","year":"2019","journal-title":"Clin Med"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:02:03Z","timestamp":1761652923000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003121","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"type":"print","value":"1077-4114"},{"type":"electronic","value":"1536-3678"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"2025-02-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}